These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Innate immunity as a target for acute cardioprotection. Zuurbier CJ; Abbate A; Cabrera-Fuentes HA; Cohen MV; Collino M; De Kleijn DPV; Downey JM; Pagliaro P; Preissner KT; Takahashi M; Davidson SM Cardiovasc Res; 2019 Jun; 115(7):1131-1142. PubMed ID: 30576455 [TBL] [Abstract][Full Text] [Related]
7. Calcium-Sensing Receptor on Neutrophil Promotes Myocardial Apoptosis and Fibrosis After Acute Myocardial Infarction via NLRP3 Inflammasome Activation. Ren Z; Yang K; Zhao M; Liu W; Zhang X; Chi J; Shi Z; Zhang X; Fu Y; Liu Y; Yin X Can J Cardiol; 2020 Jun; 36(6):893-905. PubMed ID: 32224080 [TBL] [Abstract][Full Text] [Related]
9. Role of NLRP3 Inflammasome in Cardiac Inflammation and Remodeling after Myocardial Infarction. Takahashi M Biol Pharm Bull; 2019; 42(4):518-523. PubMed ID: 30930410 [TBL] [Abstract][Full Text] [Related]
10. The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases. Toldo S; Abbate A Nat Rev Cardiol; 2024 Apr; 21(4):219-237. PubMed ID: 37923829 [TBL] [Abstract][Full Text] [Related]
11. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway. Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease. Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502 [TBL] [Abstract][Full Text] [Related]
13. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders. Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177 [TBL] [Abstract][Full Text] [Related]
14. The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse. Toldo S; Mauro AG; Cutter Z; Van Tassell BW; Mezzaroma E; Del Buono MG; Prestamburgo A; Potere N; Abbate A J Cardiovasc Pharmacol; 2019 Apr; 73(4):215-222. PubMed ID: 30747785 [TBL] [Abstract][Full Text] [Related]
15. The NLRP3 Inflammasome as a Pharmacological Target. Marchetti C J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445 [TBL] [Abstract][Full Text] [Related]